Literature DB >> 10499886

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.

A Moran1, D Hardin, D Rodman, H F Allen, R J Beall, D Borowitz, C Brunzell, P W Campbell, S E Chesrown, C Duchow, R J Fink, S C Fitzsimmons, N Hamilton, I Hirsch, M S Howenstine, D J Klein, Z Madhun, P B Pencharz, A L Quittner, M K Robbins, T Schindler, K Schissel, S J Schwarzenberg, V A Stallings, W B Zipf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10499886     DOI： 10.1016/s0168-8227(99)00058-3

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


× No keyword cloud information.
  42 in total

Review 1.  Holidays and cystic fibrosis.

Authors:  A Verma; M E Dodd; C S Haworth; A K Webb
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Authors:  Lee Dobson; Christopher D Sheldon; Andrew T Hattersley
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

3.  Ischaemic heart disease--a new issue in cystic fibrosis?

Authors:  Felicity M R Perrin; Walter Serino
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

Review 4.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

5.  Routine OGTT screening for CFRD - no thanks.

Authors:  Martin Walshaw
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

6.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

7.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

Review 8.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.

Authors:  Neda Rasouli; Stacey Seggelke; Joanna Gibbs; R Matthew Hawkins; Matthew L Casciano; Elizabeth Cohlmia; Jennifer Taylor-Cousar; Cecilia Wang; Rocio Pereira; Elisa Hsia; Boris Draznin
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

10.  Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Authors:  Antoinette Moran; Penelope Pekow; Patricia Grover; Martha Zorn; Bonnie Slovis; Joseph Pilewski; Elizabeth Tullis; Theodore G Liou; Holley Allen
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.